Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Neurología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Completado
ClinicalTrials.gov
Prospective, Multi Centre, International Registry of Male and Female Patients Newly Diagnosed With Atrial Fibrillation.
OBSERVATIONAL
Inicio: 21 de dic de 2009
ID: NCT01090362
Completado
ClinicalTrials.gov
A Multicenter, Long-Term, Active-Surveillance Study of Musculoskeletal Disorders That Occur After Initiating a Course of Levofloxacin (RWJ-25213-097) or Non-Fluoroquinolone Therapy for Acute Infectious Diseases in Children Who Were Enrolled in Phase 3 Clinical Trials Involving Levofloxacin Therapy
OBSERVATIONAL
Inicio: 1 de ago de 2002
ID: NCT00210639
Completado
Fase 3
ClinicalTrials.gov
A 52-week, Multicenter, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Efficacy, Safety, and Tolerability of an Intramuscular Depot Formulation of Aripiprazole as Maintenance Treatment in Patients With Schizophrenia
INTERVENTIONAL
Inicio: 1 de jul de 2008
ID: NCT00705783
Completado
Fase 3
ClinicalTrials.gov
A Double-Blind Multicenter Study of the Safety and Efficacy of Parecoxib Sodium/Valdecoxib and Placebo/Valdecoxib Compared to Placebo for Treatment of Post-Surgical Pain in Patients Who Have Coronary Bypass Graft Via Median Sternotomy
INTERVENTIONAL
Inicio: 1 de ene de 2003
ID: NCT00636064
Reclutando
Fase 3
ClinicalTrials.gov
Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of IV Eptinezumab in Adolescents (12-17 Years) for the Preventive Treatment of Chronic Migraine
INTERVENTIONAL
Inicio: 30 de jun de 2021
ID: NCT04965675
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase IIIB Multicenter, Randomized, Double-blind, Controlled Study to Evaluate the Efficacy, Safety and Pharmacokinetics of a Higher Dose of Ocrelizumab in Adults With Primary Progressive Multiple Sclerosis
INTERVENTIONAL
Inicio: 3 de dic de 2020
ID: NCT04548999
Completado
Fase 3
ClinicalTrials.gov
International, Multicenter, Phase IIIb Study of Subcutaneous Every-other-day Treatment of Patients With Relapsing Multiple Sclerosis With (Phase A): Double-blind Betaseron/Betaferon 250µg or 500µg or Open-label Betaseron/Betaferon 250µg and (Phase B): Open-label Betaseron/Betaferon 500µg
INTERVENTIONAL
Inicio: 1 de may de 2007
ID: NCT00459667
Completado
Fase 2
ClinicalTrials.gov
A Study to Evaluate the Efficacy and Safety of 15mg BID Losmapimod (GW856553) Compared to Placebo in Frequently Exacerbating Subjects With Chronic Obstructive Pulmonary Disease (COPD)
INTERVENTIONAL
Inicio: 9 de dic de 2014
ID: NCT02299375
Completado
Fase 2
ClinicalTrials.gov
A Phase 2a, Randomized, Active-Comparator-Controlled, Open-Label Study to Evaluate the Efficacy and Safety of Efinopegdutide (MK-6024) in Individuals With Nonalcoholic Fatty Liver Disease
INTERVENTIONAL
Inicio: 4 de ago de 2021
ID: NCT04944992
Completado
Fase 3
ClinicalTrials.gov
A Double-Blind, Randomized, Multicenter, Placebo-controlled, In-Patient, Maximum 34 Day Study of Levetiracetam Oral Solution (20-50 mg/kg/Day) as Adjunctive Treatment of Refractory Partial Onset Seizures in Pediatric Epileptic Subjects Ranging in Age From 1 Month to Less Than 4 Years of Age
INTERVENTIONAL
Inicio: 1 de oct de 2004
ID: NCT00175890
Terminado
Fase 3
ClinicalTrials.gov
An Open-label Extension to Study AVA102670 and AVA102672, to Assess the Long-term Safety and Efficacy of Rosiglitazone (Extended Release Tablets) as Adjunctive Therapy on Cognition in Subjects With Mild to Moderate Alzheimer's Disease.
INTERVENTIONAL
Inicio: 8 de ago de 2007
ID: NCT00490568
Completado
ClinicalTrials.gov
An Open-Label, Multi-Center, Follow-Up Study Designed to Evaluate the Long-Term Effects of Rasagiline in Parkinson's Disease Subjects Who Participated in the ADAGIO Study
OBSERVATIONAL
Inicio: 1 de jul de 2009
ID: NCT00936676
Completado
Fase 3
ClinicalTrials.gov
A Multi-centre, Multinational, Open-labelled, Randomised, Parallel-Group Comparison of Insulin Detemir Plus Insulin Aspart With NPH Insulin Plus Human Soluble Insulin in Subjects With Type 1 Diabetes on a Basal-Bolus Regimen
INTERVENTIONAL
Inicio: 1 de mar de 2002
ID: NCT01486940
Completado
Fase 3
ClinicalTrials.gov
A Phase IIIB Multicenter, Randomized, Double-Blind, Double-Dummy Study to Compare the Efficacy and Safety of Abatacept Administered Subcutaneously and Intravenously in Subjects With Rheumatoid Arthritis, Receiving Background Methotrexate, and Experiencing an Inadequate Response to Methotrexate
INTERVENTIONAL
Inicio: 1 de ene de 2008
ID: NCT00559585
Terminado
Fase 3
ClinicalTrials.gov
Dose Finding, Safety and Efficacy of Monthly Subcutaneous Canakinumab Administration for the Treatment of Hyperglycemia in Metformin Monotherapy Treated Type 2 Diabetic Patients: a Randomized, Double-Blind, Placebo-Controlled, Multi-Center Study
INTERVENTIONAL
Inicio: 1 de abr de 2009
ID: NCT00900146
Reclutando
Fase 3
ClinicalTrials.gov
A Phase 3, Randomized, Open-label Study Comparing Efficacy and Safety of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as a Monotherapy and in Combination With Pembrolizumab (MK-3475) Versus Treatment of Physician's Choice in Participants With Previously Untreated Locally Recurrent Unresectable or Metastatic Triple-Negative Breast Cancer Expressing PD-L1 at CPS Less Than 10 (TroFuse-011)
INTERVENTIONAL
Inicio: 16 de mar de 2025
ID: NCT06841354
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase IIIb, Global, Multicenter, Randomized, Visual Assessor-Masked Study of the Efficacy, Safety, and Pharmacokinetics of a 36-Week Refill Regimen for the Port Delivery System With Ranibizumab in Patients With Neovascular Age-Related Macular Degeneration (Velodrome)
INTERVENTIONAL
Inicio: 14 de jul de 2021
ID: NCT04657289
Completado
Fase 3
ClinicalTrials.gov
Randomised, Double-blind, Parallel-group, Placebo-controlled, Fixed-dose Study of Idalopirdine in Patients With Mild-moderate Alzheimer's Disease Treated With Donepezil
INTERVENTIONAL
Inicio: 1 de feb de 2014
ID: NCT02006641
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Active-controlled Study to Evaluate the Efficacy and Safety of Denosumab Compared With Risedronate in Glucocorticoid-treated Individuals
INTERVENTIONAL
Inicio: 28 de mar de 2012
ID: NCT01575873
Completado
Fase 3
ClinicalTrials.gov
A Single Arm, Open Label Multicentre Extension Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Patients With Multiple Sclerosis Previously Enrolled In A F. Hoffmann-La Roche Sponsored Ocrelizumab Phase IIIb/IV Clinical Trials
INTERVENTIONAL
Inicio: 12 de jul de 2018
ID: NCT03599245
Anterior
1
...
15
16
17
...
434
Siguiente
Filtros